Back to the Media roomImmuPharma jumps as follow-up study confirms safety of flagship lupus drug – Proactive Investors 28th June 2019Share this article Share on Facebook Share on Twitter
ImmuPharma jumps as follow-up study confirms safety of flagship lupus drug – Proactive Investors 28th June 2019
